Global (United States, European Union and China) 3D Printed Drugs

3D Printed Drugs Comprehensive Study by Type (Spritam, Others), Application (Personal Use, Hospitals, Clinics, Others), Distribution Channel (Medical Stores, Hospitals, Pharmaceuticals, Others), End-User (Children, Elders, Others) Players and Region - Global Market Outlook to 2028

3D Printed Drugs Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About 3D Printed Drugs
These are drugs that have been developed using 3D printing technology to adapt them to individuals more safely and effectively. These medicinal products have uniform porous structures that are easily distributed in the mouth, which means that these high-dose medicinal products do not have to be swallowed intact. Therefore, this form of medication is helpful for patients with difficulty swallowing, children, the elderly, and patients who are dealing with complications such as stroke, Alzheimer's, head and neck cancer and other neurological disorders. With 3D printed drugs, it is easy to bind multiple layers of a powder mixture (API and excipients) with an aqueous liquid to get pre-measured, leak-proof unit doses that quickly disintegrate in the mouth with just a sip of liquid. With these drugs, too, patients and caregivers can experience a rapidly disintegrating, taste-masked, and convenient way to take or administer drugs, while providers can prescribe high-dose formulations for patients with swallowing problems or stressful dosing regimens.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Aprecia Pharmaceuticals (United States), GlaxoSmithKline Plc (United Kingdom), Hewlett Packard Caribe (United States) and FabRx Ltd (United Kingdom) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global 3D Printed Drugs market by Type (Spritam and Others), Application (Personal Use, Hospitals, Clinics and Others) and Region.



On the basis of geography, the market of 3D Printed Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. Medical Stores will boost the 3D Printed Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Children will boost the 3D Printed Drugs market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increase In Adoption Of Personalized Drugs, And Production Of Combination Medicine and Rise In Awareness Pertaining To The Advantages Of These Drugs

Market Growth Drivers:
High Demand Of Instantaneous Soluble Drugs, Increasing Prevalence Of Dysphagia and Growing Usage Of 3d Printing

Challenges:
Lack of Awareness Regarding these 3D Printed Drugs in Under Developed Regions

Restraints:
Adverse Effects Of The Drugs and Lack Of Government Regulations

Opportunities:
Growing Healthcare Infrastructure, Increase In Healthcare Investments and Technological Advancements In Developing Countries

Market Leaders and their expansionary development strategies
In February 2022, Authentise, a company specializing in additive manufacturing, acquired Elements, a manufacturer of data-driven workflow software for the additive manufacturing industry. Authentise now owns all stakes in the Elements technology platform, which offers self-service workflow tools designed for manufacturing processes.
In February 2021, Glatt Pharmaceutical Services and Aprecia made an announcement to enhance the utilization of Glatt's multi-particulate technologies via Aprecia's 3DP manufacturing. This groundbreaking partnership aims to address the design obstacles encountered in conventional manufacturing for oral pharmaceuticals. By leveraging Aprecia's ZipDose™ technology, the joint effort will initially concentrate on extending the product line of existing modified release 505(b)(2) brands and expediting the clinical development of new chemical entities (NCE). The focus will be on creating dosage forms that cater to the needs of patients.
In the few last years, 3D printing of medical devices has gained worldwide attention; in particular, products such as cranial implants, artificial knees, and spine prostheses, which are personalized for each patient. Such products are marketed under current FDA regulations following their similarities with already existing medical devices. In 2017, the FDA released guidelines for the manufacturing of medical devices and implants; however, there are currently no regulatory guidelines on the 3D printing of other products. In 2015, the FDA released the first 3D printed drug product, Spritam® (levetiracetam). This great technological step led to an increase of research on 3D printing technology to produce drug delivery devices. However, despite the fast development in the field, there are legal and regulatory issues that need to be addressed.

Key Target Audience
Manufacturers of 3D Printed Drugs, Suppliers and Distributors of 3D Printed Drugs, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Spritam
  • Others
By Application
  • Personal Use
  • Hospitals
  • Clinics
  • Others
By Distribution Channel
  • Medical Stores
  • Hospitals
  • Pharmaceuticals
  • Others

By End-User
  • Children
  • Elders
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Demand Of Instantaneous Soluble Drugs
      • 3.2.2. Increasing Prevalence Of Dysphagia
      • 3.2.3. Growing Usage Of 3d Printing
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness Regarding these 3D Printed Drugs in Under Developed Regions
    • 3.4. Market Trends
      • 3.4.1. Increase In Adoption Of Personalized Drugs, And Production Of Combination Medicine
      • 3.4.2. Rise In Awareness Pertaining To The Advantages Of These Drugs
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global 3D Printed Drugs, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global 3D Printed Drugs (Value)
      • 5.2.1. Global 3D Printed Drugs by: Type (Value)
        • 5.2.1.1. Spritam
        • 5.2.1.2. Others
      • 5.2.2. Global 3D Printed Drugs by: Application (Value)
        • 5.2.2.1. Personal Use
        • 5.2.2.2. Hospitals
        • 5.2.2.3. Clinics
        • 5.2.2.4. Others
      • 5.2.3. Global 3D Printed Drugs by: Distribution Channel (Value)
        • 5.2.3.1. Medical Stores
        • 5.2.3.2. Hospitals
        • 5.2.3.3. Pharmaceuticals
        • 5.2.3.4. Others
      • 5.2.4. Global 3D Printed Drugs by: End-User (Value)
        • 5.2.4.1. Children
        • 5.2.4.2. Elders
        • 5.2.4.3. Others
      • 5.2.5. Global 3D Printed Drugs Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global 3D Printed Drugs (Volume)
      • 5.3.1. Global 3D Printed Drugs by: Type (Volume)
        • 5.3.1.1. Spritam
        • 5.3.1.2. Others
      • 5.3.2. Global 3D Printed Drugs by: Application (Volume)
        • 5.3.2.1. Personal Use
        • 5.3.2.2. Hospitals
        • 5.3.2.3. Clinics
        • 5.3.2.4. Others
      • 5.3.3. Global 3D Printed Drugs by: Distribution Channel (Volume)
        • 5.3.3.1. Medical Stores
        • 5.3.3.2. Hospitals
        • 5.3.3.3. Pharmaceuticals
        • 5.3.3.4. Others
      • 5.3.4. Global 3D Printed Drugs by: End-User (Volume)
        • 5.3.4.1. Children
        • 5.3.4.2. Elders
        • 5.3.4.3. Others
      • 5.3.5. Global 3D Printed Drugs Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global 3D Printed Drugs (Price)
      • 5.4.1. Global 3D Printed Drugs by: Type (Price)
  • 6. 3D Printed Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Aprecia Pharmaceuticals (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline Plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hewlett Packard Caribe (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. FabRx Ltd (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
  • 7. Global 3D Printed Drugs Sale, by Type, Application, Distribution Channel, End-User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global 3D Printed Drugs (Value)
      • 7.2.1. Global 3D Printed Drugs by: Type (Value)
        • 7.2.1.1. Spritam
        • 7.2.1.2. Others
      • 7.2.2. Global 3D Printed Drugs by: Application (Value)
        • 7.2.2.1. Personal Use
        • 7.2.2.2. Hospitals
        • 7.2.2.3. Clinics
        • 7.2.2.4. Others
      • 7.2.3. Global 3D Printed Drugs by: Distribution Channel (Value)
        • 7.2.3.1. Medical Stores
        • 7.2.3.2. Hospitals
        • 7.2.3.3. Pharmaceuticals
        • 7.2.3.4. Others
      • 7.2.4. Global 3D Printed Drugs by: End-User (Value)
        • 7.2.4.1. Children
        • 7.2.4.2. Elders
        • 7.2.4.3. Others
      • 7.2.5. Global 3D Printed Drugs Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global 3D Printed Drugs (Volume)
      • 7.3.1. Global 3D Printed Drugs by: Type (Volume)
        • 7.3.1.1. Spritam
        • 7.3.1.2. Others
      • 7.3.2. Global 3D Printed Drugs by: Application (Volume)
        • 7.3.2.1. Personal Use
        • 7.3.2.2. Hospitals
        • 7.3.2.3. Clinics
        • 7.3.2.4. Others
      • 7.3.3. Global 3D Printed Drugs by: Distribution Channel (Volume)
        • 7.3.3.1. Medical Stores
        • 7.3.3.2. Hospitals
        • 7.3.3.3. Pharmaceuticals
        • 7.3.3.4. Others
      • 7.3.4. Global 3D Printed Drugs by: End-User (Volume)
        • 7.3.4.1. Children
        • 7.3.4.2. Elders
        • 7.3.4.3. Others
      • 7.3.5. Global 3D Printed Drugs Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global 3D Printed Drugs (Price)
      • 7.4.1. Global 3D Printed Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. 3D Printed Drugs: by Type(USD Million)
  • Table 2. 3D Printed Drugs Spritam , by Region USD Million (2017-2022)
  • Table 3. 3D Printed Drugs Others , by Region USD Million (2017-2022)
  • Table 4. 3D Printed Drugs: by Application(USD Million)
  • Table 5. 3D Printed Drugs Personal Use , by Region USD Million (2017-2022)
  • Table 6. 3D Printed Drugs Hospitals , by Region USD Million (2017-2022)
  • Table 7. 3D Printed Drugs Clinics , by Region USD Million (2017-2022)
  • Table 8. 3D Printed Drugs Others , by Region USD Million (2017-2022)
  • Table 9. 3D Printed Drugs: by Distribution Channel(USD Million)
  • Table 10. 3D Printed Drugs Medical Stores , by Region USD Million (2017-2022)
  • Table 11. 3D Printed Drugs Hospitals , by Region USD Million (2017-2022)
  • Table 12. 3D Printed Drugs Pharmaceuticals , by Region USD Million (2017-2022)
  • Table 13. 3D Printed Drugs Others , by Region USD Million (2017-2022)
  • Table 14. 3D Printed Drugs: by End-User(USD Million)
  • Table 15. 3D Printed Drugs Children , by Region USD Million (2017-2022)
  • Table 16. 3D Printed Drugs Elders , by Region USD Million (2017-2022)
  • Table 17. 3D Printed Drugs Others , by Region USD Million (2017-2022)
  • Table 18. South America 3D Printed Drugs, by Country USD Million (2017-2022)
  • Table 19. South America 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 20. South America 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 21. South America 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 22. South America 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 23. Brazil 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 24. Brazil 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 25. Brazil 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 26. Brazil 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 27. Argentina 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 28. Argentina 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 29. Argentina 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 30. Argentina 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 31. Rest of South America 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 32. Rest of South America 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 33. Rest of South America 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 34. Rest of South America 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 35. Asia Pacific 3D Printed Drugs, by Country USD Million (2017-2022)
  • Table 36. Asia Pacific 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 37. Asia Pacific 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 38. Asia Pacific 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 39. Asia Pacific 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 40. China 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 41. China 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 42. China 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 43. China 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 44. Japan 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 45. Japan 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 46. Japan 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 47. Japan 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 48. India 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 49. India 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 50. India 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 51. India 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 52. South Korea 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 53. South Korea 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 54. South Korea 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 55. South Korea 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 56. Taiwan 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 57. Taiwan 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 58. Taiwan 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 59. Taiwan 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 60. Australia 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 61. Australia 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 62. Australia 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 63. Australia 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 68. Europe 3D Printed Drugs, by Country USD Million (2017-2022)
  • Table 69. Europe 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 70. Europe 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 71. Europe 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 72. Europe 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 73. Germany 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 74. Germany 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 75. Germany 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 76. Germany 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 77. France 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 78. France 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 79. France 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 80. France 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 81. Italy 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 82. Italy 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 83. Italy 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 84. Italy 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 85. United Kingdom 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 86. United Kingdom 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 87. United Kingdom 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 88. United Kingdom 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 89. Netherlands 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 90. Netherlands 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 91. Netherlands 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 92. Netherlands 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 93. Rest of Europe 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 94. Rest of Europe 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 95. Rest of Europe 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 96. Rest of Europe 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 97. MEA 3D Printed Drugs, by Country USD Million (2017-2022)
  • Table 98. MEA 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 99. MEA 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 100. MEA 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 101. MEA 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 102. Middle East 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 103. Middle East 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 104. Middle East 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 105. Middle East 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 106. Africa 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 107. Africa 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 108. Africa 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 109. Africa 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 110. North America 3D Printed Drugs, by Country USD Million (2017-2022)
  • Table 111. North America 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 112. North America 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 113. North America 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 114. North America 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 115. United States 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 116. United States 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 117. United States 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 118. United States 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 119. Canada 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 120. Canada 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 121. Canada 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 122. Canada 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 123. Mexico 3D Printed Drugs, by Type USD Million (2017-2022)
  • Table 124. Mexico 3D Printed Drugs, by Application USD Million (2017-2022)
  • Table 125. Mexico 3D Printed Drugs, by Distribution Channel USD Million (2017-2022)
  • Table 126. Mexico 3D Printed Drugs, by End-User USD Million (2017-2022)
  • Table 127. 3D Printed Drugs Sales: by Type(K Tons)
  • Table 128. 3D Printed Drugs Sales Spritam , by Region K Tons (2017-2022)
  • Table 129. 3D Printed Drugs Sales Others , by Region K Tons (2017-2022)
  • Table 130. 3D Printed Drugs Sales: by Application(K Tons)
  • Table 131. 3D Printed Drugs Sales Personal Use , by Region K Tons (2017-2022)
  • Table 132. 3D Printed Drugs Sales Hospitals , by Region K Tons (2017-2022)
  • Table 133. 3D Printed Drugs Sales Clinics , by Region K Tons (2017-2022)
  • Table 134. 3D Printed Drugs Sales Others , by Region K Tons (2017-2022)
  • Table 135. 3D Printed Drugs Sales: by Distribution Channel(K Tons)
  • Table 136. 3D Printed Drugs Sales Medical Stores , by Region K Tons (2017-2022)
  • Table 137. 3D Printed Drugs Sales Hospitals , by Region K Tons (2017-2022)
  • Table 138. 3D Printed Drugs Sales Pharmaceuticals , by Region K Tons (2017-2022)
  • Table 139. 3D Printed Drugs Sales Others , by Region K Tons (2017-2022)
  • Table 140. 3D Printed Drugs Sales: by End-User(K Tons)
  • Table 141. 3D Printed Drugs Sales Children , by Region K Tons (2017-2022)
  • Table 142. 3D Printed Drugs Sales Elders , by Region K Tons (2017-2022)
  • Table 143. 3D Printed Drugs Sales Others , by Region K Tons (2017-2022)
  • Table 144. South America 3D Printed Drugs Sales, by Country K Tons (2017-2022)
  • Table 145. South America 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 146. South America 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 147. South America 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 148. South America 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 149. Brazil 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 150. Brazil 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 151. Brazil 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 152. Brazil 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 153. Argentina 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 154. Argentina 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 155. Argentina 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 156. Argentina 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 157. Rest of South America 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 158. Rest of South America 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 159. Rest of South America 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 160. Rest of South America 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 161. Asia Pacific 3D Printed Drugs Sales, by Country K Tons (2017-2022)
  • Table 162. Asia Pacific 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 163. Asia Pacific 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 164. Asia Pacific 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 165. Asia Pacific 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 166. China 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 167. China 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 168. China 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 169. China 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 170. Japan 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 171. Japan 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 172. Japan 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 173. Japan 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 174. India 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 175. India 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 176. India 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 177. India 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 178. South Korea 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 179. South Korea 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 180. South Korea 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 181. South Korea 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 182. Taiwan 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 183. Taiwan 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 184. Taiwan 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 185. Taiwan 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 186. Australia 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 187. Australia 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 188. Australia 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 189. Australia 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 190. Rest of Asia-Pacific 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 191. Rest of Asia-Pacific 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 192. Rest of Asia-Pacific 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 193. Rest of Asia-Pacific 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 194. Europe 3D Printed Drugs Sales, by Country K Tons (2017-2022)
  • Table 195. Europe 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 196. Europe 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 197. Europe 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 198. Europe 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 199. Germany 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 200. Germany 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 201. Germany 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 202. Germany 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 203. France 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 204. France 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 205. France 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 206. France 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 207. Italy 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 208. Italy 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 209. Italy 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 210. Italy 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 211. United Kingdom 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 212. United Kingdom 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 213. United Kingdom 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 214. United Kingdom 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 215. Netherlands 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 216. Netherlands 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 217. Netherlands 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 218. Netherlands 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 219. Rest of Europe 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 220. Rest of Europe 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 221. Rest of Europe 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 222. Rest of Europe 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 223. MEA 3D Printed Drugs Sales, by Country K Tons (2017-2022)
  • Table 224. MEA 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 225. MEA 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 226. MEA 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 227. MEA 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 228. Middle East 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 229. Middle East 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 230. Middle East 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 231. Middle East 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 232. Africa 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 233. Africa 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 234. Africa 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 235. Africa 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 236. North America 3D Printed Drugs Sales, by Country K Tons (2017-2022)
  • Table 237. North America 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 238. North America 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 239. North America 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 240. North America 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 241. United States 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 242. United States 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 243. United States 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 244. United States 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 245. Canada 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 246. Canada 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 247. Canada 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 248. Canada 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 249. Mexico 3D Printed Drugs Sales, by Type K Tons (2017-2022)
  • Table 250. Mexico 3D Printed Drugs Sales, by Application K Tons (2017-2022)
  • Table 251. Mexico 3D Printed Drugs Sales, by Distribution Channel K Tons (2017-2022)
  • Table 252. Mexico 3D Printed Drugs Sales, by End-User K Tons (2017-2022)
  • Table 253. 3D Printed Drugs: by Type(USD/Units)
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. 3D Printed Drugs: by Type(USD Million)
  • Table 259. 3D Printed Drugs Spritam , by Region USD Million (2023-2028)
  • Table 260. 3D Printed Drugs Others , by Region USD Million (2023-2028)
  • Table 261. 3D Printed Drugs: by Application(USD Million)
  • Table 262. 3D Printed Drugs Personal Use , by Region USD Million (2023-2028)
  • Table 263. 3D Printed Drugs Hospitals , by Region USD Million (2023-2028)
  • Table 264. 3D Printed Drugs Clinics , by Region USD Million (2023-2028)
  • Table 265. 3D Printed Drugs Others , by Region USD Million (2023-2028)
  • Table 266. 3D Printed Drugs: by Distribution Channel(USD Million)
  • Table 267. 3D Printed Drugs Medical Stores , by Region USD Million (2023-2028)
  • Table 268. 3D Printed Drugs Hospitals , by Region USD Million (2023-2028)
  • Table 269. 3D Printed Drugs Pharmaceuticals , by Region USD Million (2023-2028)
  • Table 270. 3D Printed Drugs Others , by Region USD Million (2023-2028)
  • Table 271. 3D Printed Drugs: by End-User(USD Million)
  • Table 272. 3D Printed Drugs Children , by Region USD Million (2023-2028)
  • Table 273. 3D Printed Drugs Elders , by Region USD Million (2023-2028)
  • Table 274. 3D Printed Drugs Others , by Region USD Million (2023-2028)
  • Table 275. South America 3D Printed Drugs, by Country USD Million (2023-2028)
  • Table 276. South America 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 277. South America 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 278. South America 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 279. South America 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 280. Brazil 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 281. Brazil 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 282. Brazil 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 283. Brazil 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 284. Argentina 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 285. Argentina 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 286. Argentina 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 287. Argentina 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 288. Rest of South America 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 289. Rest of South America 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 290. Rest of South America 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 291. Rest of South America 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 292. Asia Pacific 3D Printed Drugs, by Country USD Million (2023-2028)
  • Table 293. Asia Pacific 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 294. Asia Pacific 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 295. Asia Pacific 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 296. Asia Pacific 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 297. China 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 298. China 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 299. China 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 300. China 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 301. Japan 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 302. Japan 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 303. Japan 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 304. Japan 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 305. India 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 306. India 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 307. India 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 308. India 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 309. South Korea 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 310. South Korea 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 311. South Korea 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 312. South Korea 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 313. Taiwan 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 314. Taiwan 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 315. Taiwan 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 316. Taiwan 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 317. Australia 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 318. Australia 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 319. Australia 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 320. Australia 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 321. Rest of Asia-Pacific 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 322. Rest of Asia-Pacific 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 323. Rest of Asia-Pacific 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 324. Rest of Asia-Pacific 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 325. Europe 3D Printed Drugs, by Country USD Million (2023-2028)
  • Table 326. Europe 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 327. Europe 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 328. Europe 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 329. Europe 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 330. Germany 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 331. Germany 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 332. Germany 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 333. Germany 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 334. France 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 335. France 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 336. France 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 337. France 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 338. Italy 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 339. Italy 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 340. Italy 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 341. Italy 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 342. United Kingdom 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 343. United Kingdom 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 344. United Kingdom 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 345. United Kingdom 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 346. Netherlands 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 347. Netherlands 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 348. Netherlands 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 349. Netherlands 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 350. Rest of Europe 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 351. Rest of Europe 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 352. Rest of Europe 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 353. Rest of Europe 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 354. MEA 3D Printed Drugs, by Country USD Million (2023-2028)
  • Table 355. MEA 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 356. MEA 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 357. MEA 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 358. MEA 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 359. Middle East 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 360. Middle East 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 361. Middle East 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 362. Middle East 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 363. Africa 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 364. Africa 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 365. Africa 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 366. Africa 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 367. North America 3D Printed Drugs, by Country USD Million (2023-2028)
  • Table 368. North America 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 369. North America 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 370. North America 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 371. North America 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 372. United States 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 373. United States 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 374. United States 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 375. United States 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 376. Canada 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 377. Canada 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 378. Canada 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 379. Canada 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 380. Mexico 3D Printed Drugs, by Type USD Million (2023-2028)
  • Table 381. Mexico 3D Printed Drugs, by Application USD Million (2023-2028)
  • Table 382. Mexico 3D Printed Drugs, by Distribution Channel USD Million (2023-2028)
  • Table 383. Mexico 3D Printed Drugs, by End-User USD Million (2023-2028)
  • Table 384. 3D Printed Drugs Sales: by Type(K Tons)
  • Table 385. 3D Printed Drugs Sales Spritam , by Region K Tons (2023-2028)
  • Table 386. 3D Printed Drugs Sales Others , by Region K Tons (2023-2028)
  • Table 387. 3D Printed Drugs Sales: by Application(K Tons)
  • Table 388. 3D Printed Drugs Sales Personal Use , by Region K Tons (2023-2028)
  • Table 389. 3D Printed Drugs Sales Hospitals , by Region K Tons (2023-2028)
  • Table 390. 3D Printed Drugs Sales Clinics , by Region K Tons (2023-2028)
  • Table 391. 3D Printed Drugs Sales Others , by Region K Tons (2023-2028)
  • Table 392. 3D Printed Drugs Sales: by Distribution Channel(K Tons)
  • Table 393. 3D Printed Drugs Sales Medical Stores , by Region K Tons (2023-2028)
  • Table 394. 3D Printed Drugs Sales Hospitals , by Region K Tons (2023-2028)
  • Table 395. 3D Printed Drugs Sales Pharmaceuticals , by Region K Tons (2023-2028)
  • Table 396. 3D Printed Drugs Sales Others , by Region K Tons (2023-2028)
  • Table 397. 3D Printed Drugs Sales: by End-User(K Tons)
  • Table 398. 3D Printed Drugs Sales Children , by Region K Tons (2023-2028)
  • Table 399. 3D Printed Drugs Sales Elders , by Region K Tons (2023-2028)
  • Table 400. 3D Printed Drugs Sales Others , by Region K Tons (2023-2028)
  • Table 401. South America 3D Printed Drugs Sales, by Country K Tons (2023-2028)
  • Table 402. South America 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 403. South America 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 404. South America 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 405. South America 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 406. Brazil 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 407. Brazil 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 408. Brazil 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 409. Brazil 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 410. Argentina 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 411. Argentina 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 412. Argentina 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 413. Argentina 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 414. Rest of South America 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 415. Rest of South America 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 416. Rest of South America 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 417. Rest of South America 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 418. Asia Pacific 3D Printed Drugs Sales, by Country K Tons (2023-2028)
  • Table 419. Asia Pacific 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 420. Asia Pacific 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 421. Asia Pacific 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 422. Asia Pacific 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 423. China 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 424. China 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 425. China 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 426. China 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 427. Japan 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 428. Japan 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 429. Japan 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 430. Japan 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 431. India 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 432. India 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 433. India 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 434. India 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 435. South Korea 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 436. South Korea 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 437. South Korea 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 438. South Korea 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 439. Taiwan 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 440. Taiwan 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 441. Taiwan 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 442. Taiwan 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 443. Australia 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 444. Australia 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 445. Australia 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 446. Australia 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 447. Rest of Asia-Pacific 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 448. Rest of Asia-Pacific 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 449. Rest of Asia-Pacific 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 450. Rest of Asia-Pacific 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 451. Europe 3D Printed Drugs Sales, by Country K Tons (2023-2028)
  • Table 452. Europe 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 453. Europe 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 454. Europe 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 455. Europe 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 456. Germany 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 457. Germany 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 458. Germany 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 459. Germany 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 460. France 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 461. France 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 462. France 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 463. France 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 464. Italy 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 465. Italy 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 466. Italy 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 467. Italy 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 468. United Kingdom 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 469. United Kingdom 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 470. United Kingdom 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 471. United Kingdom 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 472. Netherlands 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 473. Netherlands 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 474. Netherlands 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 475. Netherlands 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 476. Rest of Europe 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 477. Rest of Europe 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 478. Rest of Europe 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 479. Rest of Europe 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 480. MEA 3D Printed Drugs Sales, by Country K Tons (2023-2028)
  • Table 481. MEA 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 482. MEA 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 483. MEA 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 484. MEA 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 485. Middle East 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 486. Middle East 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 487. Middle East 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 488. Middle East 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 489. Africa 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 490. Africa 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 491. Africa 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 492. Africa 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 493. North America 3D Printed Drugs Sales, by Country K Tons (2023-2028)
  • Table 494. North America 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 495. North America 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 496. North America 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 497. North America 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 498. United States 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 499. United States 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 500. United States 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 501. United States 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 502. Canada 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 503. Canada 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 504. Canada 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 505. Canada 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 506. Mexico 3D Printed Drugs Sales, by Type K Tons (2023-2028)
  • Table 507. Mexico 3D Printed Drugs Sales, by Application K Tons (2023-2028)
  • Table 508. Mexico 3D Printed Drugs Sales, by Distribution Channel K Tons (2023-2028)
  • Table 509. Mexico 3D Printed Drugs Sales, by End-User K Tons (2023-2028)
  • Table 510. 3D Printed Drugs: by Type(USD/Units)
  • Table 511. Research Programs/Design for This Report
  • Table 512. Key Data Information from Secondary Sources
  • Table 513. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global 3D Printed Drugs: by Type USD Million (2017-2022)
  • Figure 5. Global 3D Printed Drugs: by Application USD Million (2017-2022)
  • Figure 6. Global 3D Printed Drugs: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global 3D Printed Drugs: by End-User USD Million (2017-2022)
  • Figure 8. South America 3D Printed Drugs Share (%), by Country
  • Figure 9. Asia Pacific 3D Printed Drugs Share (%), by Country
  • Figure 10. Europe 3D Printed Drugs Share (%), by Country
  • Figure 11. MEA 3D Printed Drugs Share (%), by Country
  • Figure 12. North America 3D Printed Drugs Share (%), by Country
  • Figure 13. Global 3D Printed Drugs: by Type K Tons (2017-2022)
  • Figure 14. Global 3D Printed Drugs: by Application K Tons (2017-2022)
  • Figure 15. Global 3D Printed Drugs: by Distribution Channel K Tons (2017-2022)
  • Figure 16. Global 3D Printed Drugs: by End-User K Tons (2017-2022)
  • Figure 17. South America 3D Printed Drugs Share (%), by Country
  • Figure 18. Asia Pacific 3D Printed Drugs Share (%), by Country
  • Figure 19. Europe 3D Printed Drugs Share (%), by Country
  • Figure 20. MEA 3D Printed Drugs Share (%), by Country
  • Figure 21. North America 3D Printed Drugs Share (%), by Country
  • Figure 22. Global 3D Printed Drugs: by Type USD/Units (2017-2022)
  • Figure 23. Global 3D Printed Drugs share by Players 2022 (%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Aprecia Pharmaceuticals (United States) Revenue, Net Income and Gross profit
  • Figure 26. Aprecia Pharmaceuticals (United States) Revenue: by Geography 2022
  • Figure 27. GlaxoSmithKline Plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. GlaxoSmithKline Plc (United Kingdom) Revenue: by Geography 2022
  • Figure 29. Hewlett Packard Caribe (United States) Revenue, Net Income and Gross profit
  • Figure 30. Hewlett Packard Caribe (United States) Revenue: by Geography 2022
  • Figure 31. FabRx Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. FabRx Ltd (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Global 3D Printed Drugs: by Type USD Million (2023-2028)
  • Figure 34. Global 3D Printed Drugs: by Application USD Million (2023-2028)
  • Figure 35. Global 3D Printed Drugs: by Distribution Channel USD Million (2023-2028)
  • Figure 36. Global 3D Printed Drugs: by End-User USD Million (2023-2028)
  • Figure 37. South America 3D Printed Drugs Share (%), by Country
  • Figure 38. Asia Pacific 3D Printed Drugs Share (%), by Country
  • Figure 39. Europe 3D Printed Drugs Share (%), by Country
  • Figure 40. MEA 3D Printed Drugs Share (%), by Country
  • Figure 41. North America 3D Printed Drugs Share (%), by Country
  • Figure 42. Global 3D Printed Drugs: by Type K Tons (2023-2028)
  • Figure 43. Global 3D Printed Drugs: by Application K Tons (2023-2028)
  • Figure 44. Global 3D Printed Drugs: by Distribution Channel K Tons (2023-2028)
  • Figure 45. Global 3D Printed Drugs: by End-User K Tons (2023-2028)
  • Figure 46. South America 3D Printed Drugs Share (%), by Country
  • Figure 47. Asia Pacific 3D Printed Drugs Share (%), by Country
  • Figure 48. Europe 3D Printed Drugs Share (%), by Country
  • Figure 49. MEA 3D Printed Drugs Share (%), by Country
  • Figure 50. North America 3D Printed Drugs Share (%), by Country
  • Figure 51. Global 3D Printed Drugs: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Aprecia Pharmaceuticals (United States)
  • GlaxoSmithKline Plc (United Kingdom)
  • Hewlett Packard Caribe (United States)
  • FabRx Ltd (United Kingdom)
Select User Access Type

Key Highlights of Report


Jun 2023 170 Pages 60 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global (United States, European Union and China) 3D Printed Drugs Quantitative research analysis
Global (United States, European Union and China) 3D Printed Drugs Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Aprecia Pharmaceuticals (United States), GlaxoSmithKline Plc (United Kingdom), Hewlett Packard Caribe (United States) and FabRx Ltd (United Kingdom) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increase In Adoption Of Personalized Drugs, And Production Of Combination Medicine " is seen as one of major influencing trends for 3D Printed Drugs Market during projected period 2022-2028.
The 3D Printed Drugs market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global (United States, European Union and China) 3D Printed Drugs Report?

Have a Query? Click Here

Other Related Reports

Pregnant Radiation Suits Comprehensive Study by Type (Coating Type, Multi-ionic Type, Metal Fiber Type), Application (Pregnancy 0-3 Monthes, Pregnancy 3-6 Monthes, Pregnancy>6 Monthes), Distribution ...
$ 3350
Biosensors Comprehensive Study by Application (Point-Of-Care, Home Diagnostics, Research Labs, Security & Biodefense, Environmental Monitoring, Food & Beverage Industry, Others), Type (Electrochemica...
$ 3750
Fitness APP Comprehensive Study by Type (Nutrition apps, Activity tracking apps, Workout, Exercise apps), Application (Mobiles, Tablets, Wearable devices), Deployment model (Android, Ios, Windows), C...
$ 3350
Smart Cards In Healthcare Comprehensive Study by Type (Contact-Based Smart Cards, Contactless Smart Cards, Dual-Interface Smart Cards, Hybrid Smart Cards), Application (Hospitals, Healthcare Systems,...
$ 3650
Healthcare Equipment Leasing Comprehensive Study by Type (Durable Medical Equipment (DME) Leasing, Surgery & Therapy Equipment Leasing, Personal & Home Care Equipment Leasing, Others), Application (H...
$ 3350
Healthcare Information Software Comprehensive Study by Type (Hospital Information Software, Pharmacy Information Software, Laboratory Information Software), Application (Hospitals, Clinics, Medical R...
$ 3450